• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.60% Nasdaq Down 0.39%

    Sunesis Pharmaceuticals, Inc. (SNSS)

    -NasdaqCM
    0.68 Down 0.02(2.43%) Feb 11, 4:00PM EST
    Prev Close:0.70
    Open:0.70
    Bid:0.61 x 200
    Ask:0.76 x 100
    1y Target Est:2.08
    Beta:1.34271
    Earnings Date:Mar 10 - Mar 14 (Est.)
    Day's Range:0.65 - 0.71
    52wk Range:0.65 - 3.72
    Volume:261,480
    Avg Vol (3m):300,063
    Market Cap:59.06M
    P/E (ttm):N/A
    EPS (ttm):-0.44
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SNSS

    Comparison

    Symbol% ChgMkt Cap
    SNSSDown 2.43%59.06M
    AZNUp 0.38%73.69B
    PFEDown 1.22%179.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16.07
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.49
    Quarterly EPS Est (Dec-15) :-0.14
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.01

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback